 Dimethyl Fumarate
"Dimethyl Fumarate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS.
| Descriptor ID |
D000069462
|
| MeSH Number(s) |
D02.241.081.337.302.500
|
| Concept/Terms |
Dimethyl Fumarate- Dimethyl Fumarate
- Fumarate, Dimethyl
- 2-butenedioic acid, (2E)-, dimethyl ester
- Dimethylfumarate
BG 00012- BG 00012
- 00012, BG
- BG00012
- BG-00012
FAG 201- FAG 201
- 201, FAG
- FAG201
- FAG-201
BG 12 compound- BG 12 compound
- 12 compound, BG
- compound, BG 12
- BG12 compound
- compound, BG12
- BG-12 compound
|
Below are MeSH descriptors whose meaning is more general than "Dimethyl Fumarate".
Below are MeSH descriptors whose meaning is more specific than "Dimethyl Fumarate".
This graph shows the total number of publications written about "Dimethyl Fumarate" by people in this website by year, and whether "Dimethyl Fumarate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dimethyl Fumarate" by people in Profiles.
-
Vollmer BL, Nair K, Sillau S, Corboy JR, Vollmer T, Alvarez E. Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol. 2020 09; 7(9):1466-1476.
-
Vollmer B, Ontaneda D, Harris H, Nair K, Bermel RA, Corboy JR, Fox RJ, Vollmer T, Cohen JA, Alvarez E, Hersh CM. Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up. J Neurol Sci. 2019 Dec 15; 407:116498.
-
Vollmer BL, Nair KV, Sillau S, Corboy JR, Vollmer T, Alvarez E. Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol. 2019 02; 6(2):252-262.
-
Makhani N, Schreiner T. Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study. Pediatr Neurol. 2016 Apr; 57:101-4.
-
Wang Q, Chuikov S, Taitano S, Wu Q, Rastogi A, Tuck SJ, Corey JM, Lundy SK, Mao-Draayer Y. Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway. Int J Mol Sci. 2015 Jun 17; 16(6):13885-907.
-
Zhao X, Sun G, Zhang J, Ting SM, Gonzales N, Aronowski J. Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2. Stroke. 2015 Jul; 46(7):1923-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|